A Post Marketing Surveillance to Evaluate the Safety and Efficacy of Brilinta

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2014 by AstraZeneca
Sponsor:
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT01611272
First received: May 25, 2012
Last updated: June 12, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2017
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)